Andrew Centea

Andrew Centea is a biopharma commercial leader with expertise in marketing strategy, product launch, and oncology. They have held various roles, including Global Marketing Director and Senior Manager at Amgen, and Product Manager for the Melanoma Franchise at Bristol Myers Squibb. Andrew's career spans key positions at notable companies such as AstraZeneca and GlaxoSmithKline, where they drove sales excellence in oncology and immuno-oncology. They earned a B.Sc. in Honours Biomedical Sciences from the University of Waterloo and an MBA from McMaster University, focusing on strategic marketing and entrepreneurship.